News

Sun Pharma share price: Shares of Sun Pharma Ltd., India’s largest pharmaceutical company, fell more than 4 per cent on Friday after US President Donald Trump announced 100 per cent tariffs on branded and patented drugs imported into the United States, effective October 1.

The announced tariffs will not apply to companies that already have manufacturing plants in the US, are building new facilities, or have broken ground on upcoming plants. Sun Pharma’s management has previously stated that its current US manufacturing capacity is sufficient to meet any potential onshore production requirements.

Sun Pharma’s specialty drugs, including Illumya, Cequa, Odomzo, and Winlevi, contribute 19.3 per cent of total sales. In FY25, the company reported a 17 per cent growth in specialty sales to $1.2 billion, with global Illumya sales rising 17 per cent to $681 million.

Add Zee Business as a Preferred Source

Experts, however, caution that branded tariffs may affect some products. Aditya Khemka of InCred Asset Management said, “There is a possibility of tariffs impacting Sun Pharma and Wockhardt due to branded drug imports, and biosimilars may put companies like Biocon at risk.”

The US Commerce Department clarified that prescription drugs, over-the-counter drugs, biologics, and specialty drugs are examined separately under Section 232 and are not covered under this tariff announcement.

Following the announcement, Sun Pharma shares were trading at Rs 1,571.3, down 3.5 per cent, marking a 52-week low. Prior to the tariff news, the stock had gained 1.5 per cent over the past month.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

Senior Sub-editor at Zee Business English

shweta.shukla@India.com

Shweta Birendra Shukla is a journalist covering the stock market and corporate affairs, with prior stints at Business ...LATEST NEWSBy accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.